Shaohua Xu

Title: The Innovations of Shaohua Xu

Introduction

Shaohua Xu is a prominent inventor based in Emeryville, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on targeting CD22, a protein that plays a crucial role in certain types of cancers.

Latest Patents

Shaohua Xu holds a patent titled "Constructs targeting CD22 and uses thereof." This patent describes antibodies, specifically single chain variable fragment (scFv) antibodies, and constructs that bind to the extracellular domain of CD22. The patent outlines methods for using these constructs in the therapeutic treatment of diseases characterized by CD22 expression, particularly B-cell lymphomas and leukemias. He has 1 patent to his name.

Career Highlights

Shaohua Xu is currently associated with Eureka Therapeutics, Inc., where he continues to advance his research in antibody development. His innovative approaches have the potential to lead to new treatments for patients suffering from various forms of cancer.

Collaborations

Throughout his career, Shaohua Xu has collaborated with notable colleagues, including Jun Cui and Pengbo Zhang. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Shaohua Xu's contributions to the field of biotechnology, particularly through his patent on CD22-targeting constructs, highlight his role as an influential inventor. His work at Eureka Therapeutics, Inc. continues to pave the way for advancements in cancer treatment.